Adia Nutrition Inc. has officially filed for uplisting to the OTCQB Venture Market with OTC Markets Group. This move follows the completion of an independent audit, marking a significant milestone for the company. The uplisting process, facilitated by OTC Markets, aims to enhance transparency and investor reach, and improve market maker participation. Adia Nutrition continues to expand its network of clinics and advance its innovative stem cell therapies and premium nutritional products, aiming for greater market credibility and access to a wider investor base.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.